Clinical Trial Update: Assessment of a Chronically Implanted Parasternally Delivered EV-ICD Lead (ASCEND EV) Study [NA]

View source ↗

Summary

The ASCEND EV study evaluating a chronically implanted parasternally delivered EV-ICD lead by AtaCor Medical is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Arrhythmia
• Ventricular Fibrillation
• Ventricular Tachycardia

Drugs mentioned

• EV-ICD lead

Snippet

Sponsor: AtaCor Medical, Inc. | Conditions: Ventricular Arrythmia, Ventricular Fibrillation | NA | Status: ACTIVE_NOT_RECRUITING